Trial of PICO Versus Standard Care in Chronic and Sub-acute Wounds

A 100 Patient, Prospective, Randomised, Clinical Evaluation Comparing Clinical and Health Economic Outcomes Between Patients With Chronic or Sub-acute Wounds Treated With Either PICO or Standard Care Dressings and a Qualitative Study to Explore the Experiences of Patients Receiving PICO With Particular Emphasis on Concordance

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02458859

Enrollment

Registered

2015-06-01

Start date

2012-03-31

Completion date

2015-06-30

Last updated

2018-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds

Keywords

Chronic, Subacute

Brief summary

Randomised Controlled Trial of PICO (a portable Negative Pressure Wound Therapy) versus standard care in patients with chronic and sub-acute wounds. Sample size 100 patients to investigate Time to healing, health economic and patient reported outcomes.

Detailed description

The current study is being conducted to assess the clinical and cost effectiveness of managing patients with a chronic or sub-acute wound in a community setting with PICO and to explore the patient experience and issues of concordance that affect patients treated with PICO. The study will provide information on the level of clinical benefit that PICO can deliver in the population studied in order to justify a sample size for a definitive evaluation of PICO and the study will further assess wound types that may benefit from treatment with PICO.

Interventions

DEVICEPICO (single use portable negative pressure wound therapy)

Single use portable negative pressure wound therapy

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients \>18 years old * Males and females. If female, they must not be pregnant or lactating. If female and of reproductive age, a pregnancy test will be provided. * The patient or their legal representative (if the patient is incapable of giving legal consent), is able to understand the trial and is willing to consent to the trial. * Patients with sub-acute or chronic wounds (diabetic foot ulcer, pressure ulcer, venous leg ulcer, or other chronic) suitable for treatment with a PICO dressing. * Wound duration ≤52 weeks - Amended to remove criteria. * Wound area range ≥5 cm2 at start of screening period * Wound maximum linear dimension ≤ 15cm * Able to use English for the interview

Exclusion criteria

* Patients with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing). * Wounds which have an infection which is not being treated with systemic antibiotics. * Wounds which are actively bleeding. * Exposure of blood vessels, organs, bone or tendon at the base of the reference wound * Exclude undermining or tunnelling present or suspected in the wound * Use of negative pressure device on wound in the last 30 days. Amended to remove criteria * Malignant wounds/malignancy in the wound * Systemic infection not being treated with systemic antibiotics * Simultaneous treatment with other experimental wound care procedures, biologics or devices * Patients with a known history of poor compliance with medical treatment. * Patients who have participated in this trial previously and who closed or were withdrawn. * Patients who are unable to understand the aims and objectives of the trial.

Design outcomes

Primary

Measure	Time frame	Description
Time to closure	12 weeks	Time to complete wound closure

Countries

Canada, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026